Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects [Phase 4]
An open-label, single-dose Phase 4 study to evaluate safety, tolerability, and pharmacokinetics of brodalumab in pediatric subjects with pso…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis
Clinical trial update indicates a long-term safety study of Siliq (brodalumab) versus other therapies for adults with moderate-to-severe pso…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
A clinical study evaluating how prevalent cardiovascular comorbidity is among patients with psoriasis and identifying associated risk factor…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: A Phase 2 Study of HB0017 in Psoriasis Patients [Phase 2]
Phase 2 clinical trial update for HB0017 in psoriasis, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Effects of IL17/23 Inhibitors on Markers of Subclinical Atherosclerosis in Patients With Psoriasis
The completed trial assessed how IL-17 and IL-23 inhibitors affect markers of subclinical atherosclerosis in psoriasis patients, reporting r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Microbiome and Clinical Response to Probiotics and Methotrexate in Early Psoriasis: a Pilot Study [EARLY_Phase 1]
An early Phase 1 pilot trial exploring whether probiotics combined with methotrexate can influence the microbiome and clinical response in p…
-
EMA withdrawal · 2025-09-08EMA Withdrawn: Eksunbi (ustekinumab) — Samsung Bioepis NL B.V.
The EMA has withdrawn Eksunbi (ustekinumab) from the European market as of 23 May 2025, affecting indications for Crohn's disease, ulcerativ…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Post-Marketing Surveillance Study of OTEZLA
This document reports the completion of a post-marketing surveillance study evaluating the safety of Otezla (apremilast) in patients with ps…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Pathogenesis of Periodontal Disease in Individuals With Psoriasis
This clinical trial protocol studies how periodontal disease develops in people with psoriasis. Recruitment has not yet begun.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Periodontal Health and Quality of Life in Psoriasis Patients
This clinical trial update indicates completion of a study assessing periodontal health and quality of life in patients with psoriasis.
-
CLINICAL_TRIALS withdrawal · 2025-09-04Clinical Trial Update: Safety and Effectiveness of Combined LED Light for the Treatment of Mild to Moderate Plaque Type Psoriasis Vulgaris [NA]
The clinical trial evaluating combined LED light therapy for mild-to-moderate plaque psoriasis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Evaluation of Tolerability, Efficacy and Adherence to Treatment With Wynzora Cream
A completed clinical trial evaluating tolerability, efficacy, and treatment adherence of Wynzora Cream in psoriasis patients.
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: A Multi-center RCT Clinical Trial on Personalized Precision Medicine for Patients With Psoriasis and Psoriatic Arthritis and Investigation on Cardiovascular Biomarkers [Phase 4]
This multi-center Phase 4 trial is evaluating personalized precision medicine for psoriasis and psoriatic arthritis, with an investigation o…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]
This document describes a Phase II clinical trial evaluating HSK44459 for moderate to severe plaque psoriasis, with the trial currently not …
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Analysis of Influence Factors on Osteopenia in Different Treatment of Psoriasis
This completed clinical trial analyzes factors influencing osteopenia among patients treated for psoriasis across different therapies.
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Characterization of the Fungal Immunopeptidome Involved in the Immunopathological Mechanisms of Psoriasis
This clinical trial aims to characterize the fungal immunopeptidome involved in the immunopathology of psoriasis and is currently not recrui…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
This update describes a clinical trial evaluating stigma toward patients with alopecia areata, atopic dermatitis, vitiligo, and psoriasis, c…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Impact of Clinical and Psychological Factors on Treatment Satisfaction in Psoriatic Patients in Biological Therapy
A completed clinical trial evaluated how clinical and psychological factors influence treatment satisfaction in psoriasis patients treated w…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Effectiveness of a Digital Health Application for Psoriasis [NA]
This ClinicalTrials.gov entry indicates an active but not recruiting study evaluating the effectiveness of a digital health application for …
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Molecular Inflammation Board at the Center for Personalized Medicine
A University Hospital Tuebingen clinical trial is recruiting for a personalized medicine program targeting psoriasis, psoriatic arthritis, i…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
A prospective exploratory biomarker study called SKINERGY sponsored by Leiden University Medical Center is recruiting to profile skin diseas…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Evaluation of IL 12B Genetic Polymorphism (rs3213094) [NA]
This clinical trial update from South Valley University assesses IL-12B genetic polymorphism rs3213094 in psoriasis and is currently recruit…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Is Monitoring Enhanced Auto-fluorescence Beneficial for the Precise Removal of Tissue From Psoriatic Lesions With Ablative Lasers? [NA]
Clinical trial update on whether enhanced auto-fluorescence monitoring improves precision in removing tissue from psoriatic lesions using ab…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis
This clinical trial update reports safety findings and changes in disease symptoms for risankizumab (Skyrizi) in adults with moderate-to-sev…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: IKBKB Gene Polymorphism (Single Nucleotide Polymorphism) (SNP) in Psoriatic and Psoriatic Arthritis Patients [NA]
A completed clinical trial evaluated the IKBKB gene polymorphism (SNP) in patients with psoriasis and psoriatic arthritis.